GENERAL AND HIV-1-ASSOCIATED MORBIDITY IN A RURAL UGANDAN COMMUNITY

被引:22
|
作者
WAGNER, HU
KAMALI, A
NUNN, AJ
KENGEYAKAYONDO, JF
MULDER, DW
机构
[1] MRC UK RES PROGRAMME AIDS UGANDA,POB 49,ENTEBBE,UGANDA
[2] UGANDA VIRUS RES INST,ENTEBBE,UGANDA
关键词
HIV-1; MORBIDITY; RURAL POPULATION; UGANDA; AIDS CLINICAL CASE DEFINITION;
D O I
10.1097/00002030-199311000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: The AIDS epidemic in sub-Saharan Africa affects whole communities, adding to the. already high burden of morbidity. Reports of AIDS cases are usually from hospital attenders, often diagnosed using the World Health Organization (WHO) clinical case definition. Little is known about the extent of HIV-associated morbidity in the general population. The objectives of this study were to describe the prevalence of (1) markers of general morbidity and (2) the criteria of the WHO clinical case definition for AIDS and (3) to determine the association between these markers and HIV-1 serostatus in a rural Ugandan community. Methods: A survey was conducted among the adult population (aged greater-than-or-equal-to 13 years) of 15 neighbouring villages in Masaka District, south-west Uganda. The survey included medical history, physical examination and testing for HIV-1 antibodies. Results: The HIV-1 seroprevalence among 4175 out of 5278 (79%) eligible adults was 8.2%. Current health problems were reported by 57.6% of adults, with increased rates in HIV-1-positive subjects, women and older people. Five of the 10 most common complaints showed significant associations with HIV-1 status, as did reported genital ulcer and vaginal discharge. The crude HIV-1 attributable disease burden in the population was 1.2% for current illness, 4.3% for previous serious illness and 9.9% for illness leading to hospital admission. Overall, 11 (3.3%) of the HIV-1-positive and nine (0.2%) of the HIV-1-negative subjects had AIDS as defined by the clinical case definition. The positive and negative predictive values and specificity were 55.0, 92.0%, and 99.8%, respectively. Conclusions: Against a background of high general morbidity, we observed a relatively small population attribution of HIV-1-associated morbidity. The results indicate that the clinical AIDS case definition may provide a useful tool for population surveys.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 50 条
  • [21] Role of IL-15 in HIV-1-associated hypergammaglobulinaemia
    Kacani, L
    Stoiber, H
    Dierich, MP
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (01): : 14 - 18
  • [22] THE IMPACT OF AIDS IN A RURAL UGANDAN COMMUNITY
    KONDELULE, JK
    SEBINA, AJN
    [J]. EAST AFRICAN MEDICAL JOURNAL, 1993, 70 (11) : 725 - 729
  • [23] Strategies in the treatment of HIV-1-associated adipose redistribution syndromes
    Gutierrez, Maria del Mar
    Mateo, Gracia
    Domingo, Pere
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (12) : 1871 - 1884
  • [24] Timing of Antiretroviral Therapy for HIV-1-Associated Tuberculosis REPLY
    Blanc, Francois-Xavier
    Laureillard, Didier
    Goldfeld, Anne E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05): : 475 - 475
  • [25] Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders
    Liu, Han
    Xu, Enquan
    Liu, Jianuo
    Xiong, Huangui
    [J]. BRAIN SCIENCES, 2016, 6 (03)
  • [26] Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
    Borrajo Lopez, Ana
    Aranzazu Penedo, Maria
    Rivera-Baltanas, Tania
    Perez-Rodriguez, Daniel
    Alonso-Crespo, David
    Fernandez-Pereira, Carlos
    Manuel Olivares, Jose
    Carlos Agis-Balboa, Roberto
    [J]. BIOMEDICINES, 2021, 9 (08)
  • [27] Is PPARγ a Prospective Player in HIV-1-Associated Bone Disease?
    Cotter, Eoin J.
    Mallon, Patrick W.
    Doran, Peter P.
    [J]. PPAR RESEARCH, 2009, 2009
  • [28] CYTOKINE EXPRESSION OF MACROPHAGES IN HIV-1-ASSOCIATED VACUOLAR MYELOPATHY
    TYOR, WR
    GLASS, JD
    BAUMRIND, N
    MCARTHUR, JC
    GRIFFIN, JW
    BECKER, PS
    GRIFFIN, DE
    [J]. NEUROLOGY, 1993, 43 (05) : 1002 - 1009
  • [29] Potentiation of excitotoxicity in HIV-1-associated Dementia and the significance of glutaminase
    Erdmann, Nathan B.
    Whitney, Nicholas P.
    Zheng, Jialin
    [J]. CLINICAL NEUROSCIENCE RESEARCH, 2006, 6 (05) : 315 - 328
  • [30] NEUROBEHAVIORAL AND NEUROIMAGING CORRELATIONS IN HIV-1-ASSOCIATED DEMENTIA COMPILER
    ORTEGO, JN
    CHANG, L
    MILLER, BL
    OROPILLA, G
    MEYER, H
    SATZ, P
    MENA, I
    [J]. NEUROLOGY, 1994, 44 (04) : A248 - A248